Naturland Holding Zrt (BUD:NATURLAND) EBIT: Ft1,571 Mil (TTM As of Jun. 2025)


BUD:NATURLAND Naturland Holding Zrt BUD:NATURLAND
61 GF Score
Price Ft2,820.00
GF Value Ft2,879.22
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Naturland Holding Zrt EBIT?

Naturland Holding Zrt BUD:NATURLAND 61 EBIT is Ft1,571 Mil as of Jun. 2025. GuruFocus rates BUD:NATURLAND with a GF Score™ of 61/100 and a GF Value™ of Ft2,879.22 (Fairly Valued). The stock has 6 warning signs investors should review.

Naturland Holding Zrt's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2025 was Ft767 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2025 was Ft1,571 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Naturland Holding Zrt's annualized ROC % for the quarter that ended in Jun. 2025 was 54.98%. Naturland Holding Zrt's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2025 was 49.94%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Naturland Holding Zrt's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2025 was 4.05%.


Naturland Holding Zrt  (BUD:NATURLAND) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Naturland Holding Zrt's annualized ROC % for the quarter that ended in Jun. 2025 is calculated as:

ROC % (Q: Jun. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2024 ) + Invested Capital (Q: Jun. 2025 ))/ count )
=2105.354 * ( 1 - 5.39% )/( (3635.458 + 3610.528)/ 2 )
=1991.8754194/3622.993
=54.98 %

where

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4843.065 - 401.813 - ( 805.794 - max(0, 913.725 - 2542.755+805.794))
=3635.458

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4370.448 - 446.059 - ( 313.861 - max(0, 949.79 - 2023.754+313.861))
=3610.528

Note: The Operating Income data used here is two times the semi-annual (Jun. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Naturland Holding Zrt's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2024  Q: Jun. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1533.602/( ( (2258.476 + max(819.514, 0)) + (2293.658 + max(770.723, 0)) )/ 2 )
=1533.602/( ( 3077.99 + 3064.381 )/ 2 )
=1533.602/3071.1855
=49.94 %

where Working Capital is:

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(550.73 + 1141.832 + 12.167) - (401.813 + 0 + 483.402)
=819.514

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(518.44 + 1151.926 + 22.702) - (446.059 + 0 + 476.286)
=770.723

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Naturland Holding Zrt's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2025 )
=1570.729/38806.000
=4.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Naturland Holding Zrt EBIT Related Terms


Naturland Holding Zrt EBIT Historical Data

* Premium members only.

The historical data trend for Naturland Holding Zrt's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Naturland Holding Zrt EBIT Chart

Naturland Holding Zrt Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
194.80 1,140.36 1,371.76 1,263.75 1,523.74

Naturland Holding Zrt Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
EBIT Get a 7-Day Free Trial Premium Member Only 615.94 647.81 719.81 803.93 766.80

BUD:NATURLAND vs ZTS, UTHR, VTRS: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Naturland Holding Zrt's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Naturland Holding Zrt EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Naturland Holding Zrt's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Naturland Holding Zrt's EV-to-EBIT falls into.


BUD:NATURLAND
61GF Score
Naturland Holding Zrt BUD:NATURLAND
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Naturland Holding Zrt EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was Ft1,571 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of Ft1,571 Mil mean?
Naturland Holding Zrt (BUD:NATURLAND) has a EBIT of Ft1,571 Mil as of Jun. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Naturland Holding Zrt.
Is Naturland Holding Zrt's EBIT too high?
Naturland Holding Zrt's current EBIT is Ft1,571 Mil. Overall, Naturland Holding Zrt has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Naturland Holding Zrt's EBIT compare to ZTS and UTHR?
Naturland Holding Zrt's EBIT of Ft1,571 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Naturland Holding Zrt. Naturland Holding Zrt's current EBIT is Ft1,571 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturland Holding Zrt stock overvalued right now?
Based on GuruFocus' analysis, Naturland Holding Zrt (BUD:NATURLAND) is currently considered Fairly Valued. The stock's GF Value™ is Ft2,879.22, compared to a current price of Ft2,820.00 — trading 2.1% below its estimated fair value. The current EBIT is Ft1,571 Mil. Naturland Holding Zrt's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Naturland Holding Zrt (BUD:NATURLAND), the current EBIT is Ft1,571 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Naturland Holding Zrt (BUD:NATURLAND) Overvalued in 2026?

Based on GuruFocus' analysis, Naturland Holding Zrt stock appears to be undervalued. The current stock price of Ft2,820.00 is trading 2.1% below its estimated GF Value™ of Ft2,879.22. GuruFocus considers Naturland Holding Zrt to be Fairly Valued.

Key valuation signals for BUD:NATURLAND:

  • EBIT: Ft1,571 Mil
  • GF Value™: Ft2,879.22 vs. price of Ft2,820.00 (2.1% below fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the BUD:NATURLAND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Naturland Holding Zrt Business Description

Address Csillagvirag utca 8, Budapest, HUN, 1106
Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.
61GF Score

Get the complete analysis for BUD:NATURLAND

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Ft2,820.00
Price
Ft2,879.22
GF Value